Navigation Links
Accera, Inc. Completes $35 Million Series C Financing
Date:11/11/2008

BROOMFIELD, Colo., Nov. 11 /PRNewswire/ -- Accera, Inc., a biotechnology company delivering breakthrough therapies in central nervous system diseases, announced it has recently closed a Series C financing round of $35 million (euro 27 million), led by Inventages Venture Capital SA. Proceeds of this financing will be used to begin sales and marketing of the company's lead product, Axona(TM) (previously known as Ketasyn), which is scheduled to launch in the United States in the first quarter of 2009.

Inventages was joined in this round by San Diego-based POSCO BioVentures and other previous private investors. Inventages and POSCO participated in the Company's Series A and B rounds.

Steve Orndorff, Ph.D., Accera's founder and CEO, said, "Closing this transaction in the current difficult financial environment is a testament to the confidence of our investors in the Accera organization and the potential of Axona".

Wolfgang Reichenberger, Ph.D., general partner, Inventages WHealth Management Inc. and IVC Americas SA and a member of Accera's Board of Directors, expressed enthusiasm about the commercial direction of the company and the upcoming launch of Axona. "Metabolic intervention is a new approach to neurodegenerative diseases, and Accera is a clear leader. We are pleased to support the commercialization of Axona as the lead product from this novel technology platform," Reichenberger said.

About Accera, Inc.

Accera, Inc., a privately held biotechnology company, discovers and develops breakthroughs in central nervous systems disorders. Accera's novel approaches positively impact patients with neurodegenerative disorders who are in need of effective, well-tolerated therapies. Through its proprietary scientific platform, Accera is developing products that address metabolic deficiencies by providing an alternative energy source for the brain. For more information, visit http://www
'/>"/>

SOURCE Accera, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Accera, Inc. Names William T. Poncy Vice President of Commercial Development
2. Accera, Inc. to Present at the 4th Annual BIO Investor Forum
3. OncoMed Pharmaceuticals Completes Series B Financing
4. Avantium Completes EUR 18 Million Financing Round
5. Advanced Life Sciences Completes Debt Transaction
6. American Oriental Bioengineering Completes Two Acquisitions
7. Acasti Pharma completes offer to exchange outstanding Neptune Technologies dividend notes
8. Peregrine Pharmaceuticals Completes Patient Enrollment In First Stage of Bavituximab Phase II Lung Cancer Trial
9. S*BIO Completes US$26 Million Equity Financing
10. Shengtai Pharmaceutical Completes Factory Improvements Resulting in Operational and Environmental Benefits
11. CeNeRx BioPharma Completes $15 Million Series B Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: 6 p.m. – ... Warrington, Pa. , Details: The Hepatitis B Foundation, ... cure for hepatitis B and improving the quality of life ... on Friday, April 11 at Warrington Country Club in Warrington, ...
(Date:1/14/2014)... 2014 EquitiesIQ, a leading informational research ... Alliqua is an emerging biomedical company acquiring, developing, manufacturing, ... market. , Free report download: http://equitiesiq.com/reports/alliqua/ , ... management team and Board, which launched the company’s new ...
(Date:1/14/2014)... , Jan. 14, 2014  RXi Pharmaceuticals Corporation (OTCQX: ... and commercializing innovative therapies addressing major unmet medical ... received the Notice of Allowance from the United ... self-delivering RNAi compounds (sd-rxRNA®), for the treatment of ...
(Date:1/14/2014)... During the 1600’s through the 1800’s doctors contributed unknowingly ... this time period, doctors did not know that they needed ... death of vulnerable patients. In the same way, medical interns ... unwittingly transmitting herpes viruses to their patients. The CBCD explains. ...
Breaking Biology Technology:Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3
... Milwaukee, Wis. - The life sciences, transportation, and ... collaboration between the cities of Milwaukee and Madison, according to ... appeared with Madison Mayor Dave Cieslewicz in a ... cities are making progress on their M2 Collaborative and their ...
... week from a 15-day tour of some of Australia and ... IT companies because unlike in the States, where the Web ... marketplace hasnt been captivated by the same frenzy. Indeed, of ... through the major tech venues of the region, only two ...
... high-stakes game of citywide wireless Internet, do deep pockets trump local ... example, the answer might be yes. Earlier this year, Milwaukee was ... in the nation. City officials hoped to have some areas of ... now it looks as though wireless hot spots will have to ...
Cached Biology Technology:Cieslewicz, Barrett talk economic collaboration 2Cieslewicz, Barrett talk economic collaboration 3Cieslewicz, Barrett talk economic collaboration 4Start-ups "down under" not captivated by Web 2.0 2Start-ups "down under" not captivated by Web 2.0 3Milwaukee runs out of patience with wireless Internet provider 2Milwaukee runs out of patience with wireless Internet provider 3
(Date:4/18/2014)... researchers have published soil organic carbon sequestration rates. ... organic carbon can be sequestered by simply switching from ... there is a growing body of research with evidence ... cover crops, small grains, and forages may not be ... , "Some studies have shown that both moldboard and ...
(Date:4/18/2014)... Durham, NC Seeds that sprout as soon as they,re ... plants need to be more careful. In the wild, a ... rainy day would risk disaster. More than just an insurance ... out that seed dormancy has long-term advantages too: Plants ... give rise to more species, finds in a team of ...
(Date:4/18/2014)... led by a University of California, Riverside professor of ... Department of Defense grant to uncover fundamental design rules ... predictable design of light-weight, tough and strong advanced materials ... and animals, including the mantis shrimp, toucan and bamboo. ... over millions of years and coming up with design ...
Breaking Biology News(10 mins):Researchers question published no-till soil organic carbon sequestration rates 2Researchers question published no-till soil organic carbon sequestration rates 3Researchers question published no-till soil organic carbon sequestration rates 4Plants with dormant seeds give rise to more species 2Mantis shrimp, toucan and trilobite, oh my 2Mantis shrimp, toucan and trilobite, oh my 3
... rise, some species of corals are likely to succeed at ... on April 12 in the Cell Press journal Current ... effects on corals. "The good news is that, rather ... change by changing the mix of coral species as the ...
... fit frogs have faster-changing genomes, says a new study ... Stretches of DNA accumulate changes over time, but the ... between species, said author Juan C. Santos of the ... In the past, biologists trying to explain why some ...
... cause hearing damage to Sailors and Marines on flight ... funding a new project to help reduce jet noise, ... into two categories: noise exposure on the flight deck ... said Dr. Brenda Henderson, deputy manager for the Jet ...
Cached Biology News:Under climate change, winners and losers on the coral reef 2Athletic frogs have faster-changing genomes 2ONR taps research teams to help reduce jet noise 2
MAb to Mouse MHC Class I H-2Kd...
... contains a unique β-agarose digesting enzyme developed ... intact DNA and RNA from low melting ... TAE, TBE, MOPS, or phosphate buffers. The ... TAE, TBE, MOPS, and phosphate electrophoresis buffers ...
... a unique β-agarose digesting enzyme developed at ... DNA and RNA from low melting point ... TBE, MOPS, or phosphate buffers. The gel ... TBE, MOPS, and phosphate electrophoresis buffers or ...
... Perhaps sheer in-house demand is causing shortages ... your precious antibody. This can cause unwanted ... • Receive royalties for your hard work ... let us build it up and market ...
Biology Products: